Halloween Special Affielisa® Rat Solute Carrier Family 2, Facilitated Glucose Transporter Member 1 Elisa [ Slc2a1] Collection [thpJMfxj]
AffiELISA® Rat Solute Carrier Family 2, Facilitated Glucose Transporter Member 1 ELISA The AffiELISA® Rat Solute Carrier Family 2, Facilitated Glucose Transporter Member 1 ELISA [Slc2a1] is a highly sensitive and specific assay designed for the quant
Secure Shopping
100% Safe Guarantee
Free Shipping
On orders over $30
Money-Back
30-Day Guarantee
AffiELISA® Rat Solute Carrier Family 2, Facilitated Glucose Transporter Member 1 ELISA
The AffiELISA® Rat Solute Carrier Family 2, Facilitated Glucose Transporter Member 1 ELISA [Slc2a1] is a highly sensitive and specific assay designed for the quantitative measurement of Slc2a1 protein in rat samples. This assay kit is an essential tool for researchers studying glucose metabolism, insulin sensitivity, and related pathologies. With its robust performance and ease of use, it offers a reliable solution for accurate and reproducible results.Product Features and Specifications
The AffiELISA® Rat Solute Carrier Family 2, Facilitated Glucose Transporter Member 1 ELISA [Slc2a1] is equipped with the following features and specifications:- High Sensitivity: Detects low levels of Slc2a1 protein with exceptional accuracy, ensuring reliable results even in complex sample matrices.
- Specificity: Minimizes cross-reactivity with other proteins, providing precise measurements of Slc2a1 levels.
- Simple Protocol: The streamlined procedure is easy to follow, saving time and reducing the risk of errors.
- High Throughput: The kit is suitable for high-volume assays, allowing for efficient analysis of multiple samples.
Practical Uses and Benefits
The AffiELISA® Rat Solute Carrier Family 2, Facilitated Glucose Transporter Member 1 ELISA [Slc2a1] is widely applicable in various research areas:- Diabetes Research: Investigates the role of Slc2a1 in glucose uptake and insulin sensitivity, aiding in the understanding of diabetes pathophysiology.
- Metabolic Disorders: Assesses the expression and function of Slc2a1 in metabolic diseases, such as obesity and metabolic syndrome.
- Drug Development: Facilitates the identification and characterization of novel therapeutic targets for glucose metabolism-related disorders.
What Our Customers Say
Absolutely no complaints!
So well made. I am exceptionally so very happy.
- Ysbaddaden R..
Absolutely no complaints!
This product is a definite and a very solid home run.
- Vanora C..
Absolutely no complaints!
This is a very good and a very, very, very great tool.
- Goreu F..